Christensen M S, Nielsen H E
Scand J Urol Nephrol Suppl. 1977(42):130-3.
Hypercalcemia after renal transplantation (post-TH) was detected in 32 (17%) of 188 long-term survivors. The mean time from renal transplantation (RT) till onset of post-TH was 60 (3-210) days. In 19 patients the hypercalcemia was mild and transient, resolving spontaneously within 1-65 (mean 18) months. In 6 patients s-calcium normalized simultaneously with a rejection episode treated with increased prednisone doses. The hypercalcemia was more pronounced (permanent) in 7 patients, and terminated by subtotal parathyroidectomy in 5 and still persists in 2. The hypercalcemia was asymptomatic and did not affect the function of the graft except in one patient who developed calculi in the graft and a fall in graft function, all of which disappeared after subtotal parathyroidectomy. The frequency of aseptic bone necrosis and spontaneous fractures was the same in recipients with and without post-TH. Serum parathyroid hormone (s-PTH) was significantly higher in patients with permanent than in those with transient post-TH, who had the same slight elevation of s-PTH as the normocalcemic recipients. A permanent course of post-TH can be expected when both s-calcium and s-PTH are persistingly elevated.
188名长期存活者中有32名(17%)在肾移植后(移植后)出现高钙血症。从肾移植(RT)到移植后高钙血症发作的平均时间为60(3 - 210)天。19名患者的高钙血症为轻度且短暂,在1 - 65(平均18)个月内自发缓解。6名患者的血清钙在增加泼尼松剂量治疗排斥反应时同时恢复正常。7名患者的高钙血症更明显(持续存在),5名患者通过甲状旁腺次全切除术终止,2名患者仍持续存在。高钙血症无症状,除1名患者移植肾出现结石且移植肾功能下降外,均未影响移植肾的功能,甲状旁腺次全切除术后所有症状均消失。有或无移植后高钙血症的受者无菌性骨坏死和自发性骨折的发生率相同。永久性移植后高钙血症患者的血清甲状旁腺激素(s - PTH)显著高于短暂性移植后高钙血症患者,短暂性移植后高钙血症患者的s - PTH升高程度与血钙正常的受者相同。当血清钙和s - PTH持续升高时,可预期为永久性移植后高钙血症病程。